PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

作者: Tarek A. Bismar , Maisa Yoshimoto , Robin T. Vollmer , Qiuli Duan , Matthew Firszt

DOI: 10.1111/J.1464-410X.2010.09470.X

关键词: Tumor progressionProstate cancerCancerErgPTENTumor suppressor geneCancer researchFluorescence in situ hybridizationGene rearrangementMedicine

摘要: What’s known on the subject? and What does study add? So far we know that ERG rearrangements PTEN deletions interact to induce prostate cancer in transgenic mice. The confirms an association also exists between two genetic aberrations human cancer, as there is increased incidence of cases with rearrangements. OBJECTIVE To investigate interaction between, significance of, gene genomic relation development progression (PCA). PATIENTS AND METHODS We interrogated initial cohort 220 men localized PCA using fluorescence situ hybridization for deletions. RESULTS The incidences were significantly higher than high-grade prostatic intra-epithelial neoplasia (HGPIN) benign tissue (P < 0.001). detected 41.9 42.6% patients’ tumours, respectively. never tissue, while present at a basal level 4.6%. hemizygous showed frequency homozygous within each diagnostic category from HGPIN (P ≤ 0.001). Furthermore, 29 patients where all three tissues available, different those (P = 0.005) (P = 0.02), reflecting accumulation early stages disease progression. Within this cohort, 71.4% 44.2% occurred simultaneously (P ≈ 0). Stratified according Gleason score (GS), across various GS groups observed deletions. However, positive trends GS, increasing poorly differentiated (GS 8–10) comparison moderately well tumours 6 7). CONCLUSION We show significant subset PCA. Our analysis provides further support observation can occur lesions, shows accumulating progression, evidenced by detection more 8–10 6–7.

参考文章(46)
Scott A. Tomlins, Bharathi Laxman, Sooryanarayana Varambally, Xuhong Cao, Jindan Yu, Beth E. Helgeson, Qi Cao, John R. Prensner, Mark A. Rubin, Rajal B. Shah, Rohit Mehra, Arul M. Chinnaiyan, Role of the TMPRSS2-ERG gene fusion in prostate cancer Neoplasia. ,vol. 10, pp. 177- 188 ,(2008) , 10.1593/NEO.07822
Brett S Carver, Jennifer Tran, Anuradha Gopalan, Zhenbang Chen, Safa Shaikh, Arkaitz Carracedo, Andrea Alimonti, Caterina Nardella, Shohreh Varmeh, Peter T Scardino, Carlos Cordon-Cardo, William Gerald, Pier Paolo Pandolfi, Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nature Genetics. ,vol. 41, pp. 619- 624 ,(2009) , 10.1038/NG.370
Marta Winnes, Erik Lissbrant, Jan-Erik Damber, Göran Stenman, Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer. Oncology Reports. ,vol. 17, pp. 1033- 1036 ,(2007) , 10.3892/OR.17.5.1033
Jacques Lapointe, Chunde Li, Craig P. Giacomini, Keyan Salari, Stephanie Huang, Pei Wang, Michelle Ferrari, Tina Hernandez-Boussard, James D. Brooks, Jonathan R. Pollack, Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis Cancer Research. ,vol. 67, pp. 8504- 8510 ,(2007) , 10.1158/0008-5472.CAN-07-0673
Karin G. Hermans, Joost L. Boormans, Delila Gasi, Geert J.H.L. van Leenders, Guido Jenster, Paul C.M.S. Verhagen, Jan Trapman, Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer. Clinical Cancer Research. ,vol. 15, pp. 6398- 6403 ,(2009) , 10.1158/1078-0432.CCR-09-1176
Sven Perner, Francesca Demichelis, Rameen Beroukhim, Folke H. Schmidt, Juan-Miguel Mosquera, Sunita Setlur, Joelle Tchinda, Scott A. Tomlins, Matthias D. Hofer, Kenneth G. Pienta, Rainer Kuefer, Robert Vessella, Xiao-Wei Sun, Matthew Meyerson, Charles Lee, William R. Sellers, Arul M. Chinnaiyan, Mark A. Rubin, TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer Cancer Research. ,vol. 66, pp. 8337- 8341 ,(2006) , 10.1158/0008-5472.CAN-06-1482
Francesca Demichelis, Sunita R. Setlur, Rameen Beroukhim, Sven Perner, Jan O. Korbel, Christopher J. LaFargue, Dorothee Pflueger, Cara Pina, Matthias D. Hofer, Andrea Sboner, Maria A. Svensson, David S. Rickman, Alex Urban, Michael Snyder, Matthew Meyerson, Charles Lee, Mark B. Gerstein, Rainer Kuefer, Mark A. Rubin, Distinct genomic aberrations associated with ERG rearranged prostate cancer. Genes, Chromosomes and Cancer. ,vol. 48, pp. 366- 380 ,(2009) , 10.1002/GCC.20647
Wen Hong Shen, Adayabalam S. Balajee, Jianli Wang, Hong Wu, Charis Eng, Pier Paolo Pandolfi, Yuxin Yin, Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity Cell. ,vol. 128, pp. 157- 170 ,(2007) , 10.1016/J.CELL.2006.11.042
Michael M. Shen, Cory Abate-Shen, Pten inactivation and the emergence of androgen-independent prostate cancer. Cancer Research. ,vol. 67, pp. 6535- 6538 ,(2007) , 10.1158/0008-5472.CAN-07-1271
G Attard, , J Clark, L Ambroisine, G Fisher, G Kovacs, P Flohr, D Berney, C S Foster, A Fletcher, W L Gerald, H Moller, V Reuter, J S De Bono, P Scardino, J Cuzick, C S Cooper, Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer Oncogene. ,vol. 27, pp. 253- 263 ,(2008) , 10.1038/SJ.ONC.1210640